$1,000 in Zoetis (ZTS) Stock a Decade Ago? Here’s the Jaw-Dropping Result Today

Zoetis (ZTS) quietly minted fortunes while Wall Street slept. The animal health giant’s stock didn’t just climb—it bulldozed through market cycles like a bull in a china shop.

From vet bills to velvet returns

Pet parents kept spending through recessions, pandemics, and crypto crashes—padding Zoetis’ bottom line while ‘disruptive’ tech plays evaporated. The company turned flea collars and livestock vaccines into a shareholder wealth machine.

The numbers don’t lie (unlike some earnings calls)

That hypothetical $1,000 investment? It’s now worth [original data amount]—proving sometimes the boring bets leave flashy tech stocks in the dust. Meanwhile, traders who chased meme stocks are still waiting for their ‘squeeze’.

Animal healthcare outperformed because it’s recession-proof, tech-immune, and fueled by humanity’s irrational devotion to pets. The next decade? Zoetis keeps printing money—while crypto bros argue about ‘adoption curves’.

Image source: Getty Images.

Another appealing detail is that Zoetis is somewhat recession-proof, because taking care of animals' health is not optional for many people. Livestock need to stay healthy for business purposes and pets are often considered valuable members of families.

Finally, Zoetis is a dividend-paying stock, with a recent dividend yield of 1.3%. That may not seem like much, but the total annual payout, recently $1.93 per share, is up from $1.30 in 2022 and $0.50 in 2018. Shares seem undervalued at recent levels, too, with the recent forward-looking price-to-earnings (P/E) ratio of 24 is well below the five-year average of 32.